Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

Remdantry (infliximab for injection) is a biosimilar to the reference biologic drug Remicade, that consists of a chimeric immunoglobulin G1 (IgG1) monoclonal antibody that binds with high affinity to ...

The legal battle involving Sigrima, Zydus Lifesciences’ biosimilar version of Roche’s breast cancer drug Pertuzumab, has taken a fresh turn, and this could affect further generic competition ...

The Association for Accessible Medicines’ annual U.S. Generic & Biosimilar Medicines Savings Report, in partnership with the IQVIA Institute, reveals that the use of Food and Drug Administration ...

What Is a Gantt Chart and How Does It Work? Your email has been sent Learn how to manage projects by using a Gantt chart, and which industries and project types it would benefit most. Discover the ...

Within the first 2 years, biosimilars had less than 30% of the market share compared with most biologic drugs facing competition. In 2023 alone, specialty medicines accounted for 54% of spending ...

Again using generics as an example, patients initially were skeptical as they were concerned that these products were lesser than the branded drugs they may have already been taking. Biosimilars ...

The US pharmaceuticals watchdog has published a bullish assessment of a copycat biotech drug, paving the way for it to approve its first ever “biosimilar” — a novel category of medicine that ...

Her expertise is in personal finance and investing, and real estate. Theresa Chiechi / Investopedia A Gantt chart is a commonly used graphical depiction of a project schedule. It’s a type of bar ...

Shanghai: A Chinese drugmaker has developed a biosimilar version of Novo Nordisk's popular diabetes drug Oempic and applied for its approval. Hangzhou Jiuyuan Gene Engineering said on Wednesday in ...

There's a catch, however. Developing a biosimilar is much more challenging than developing a generic version of a chemically synthesized "small molecule" drug. That's because biosimilars ...